Mitsubishi UFJ Asset Management (UK)’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $326K | Hold |
5,000
| – | – | 0.17% | 95 |
|
2025
Q1 | $335K | Buy |
+5,000
| New | +$335K | 0.18% | 93 |
|
2024
Q3 | – | Sell |
-4,000
| Closed | -$255K | – | 115 |
|
2024
Q2 | $255K | Hold |
4,000
| – | – | 0.13% | 95 |
|
2024
Q1 | $277K | Hold |
4,000
| – | – | 0.14% | 97 |
|
2023
Q4 | $221K | Sell |
4,000
-6,000
| -60% | -$332K | 0.12% | 82 |
|
2023
Q3 | $581K | Sell |
10,000
-5,000
| -33% | -$291K | 0.41% | 79 |
|
2023
Q2 | $807K | Hold |
15,000
| – | – | 0.52% | 62 |
|
2023
Q1 | $596K | Sell |
15,000
-8,000
| -35% | -$318K | 0.39% | 79 |
|
2022
Q4 | $925K | Hold |
23,000
| – | – | 0.65% | 54 |
|
2022
Q3 | $739K | Hold |
23,000
| – | – | 0.57% | 59 |
|
2022
Q2 | $682K | Hold |
23,000
| – | – | 0.39% | 68 |
|
2022
Q1 | $647K | Buy |
23,000
+7,000
| +44% | +$197K | 0.29% | 84 |
|
2021
Q4 | $737K | Hold |
16,000
| – | – | 0.31% | 77 |
|
2021
Q3 | $525K | Buy |
+16,000
| New | +$525K | 0.22% | 83 |
|
2019
Q4 | – | Sell |
-13,000
| Closed | -$947K | – | 80 |
|
2019
Q3 | $947K | Hold |
13,000
| – | – | 0.44% | 59 |
|
2019
Q2 | $1.07K | Buy |
+13,000
| New | +$1.07K | 0.01% | 62 |
|